Reports
Sale
Global Sedation in ICU Setting Market Share, Size, Analysis, Growth, Forecast: By Drug Class: Propofol, Benzodiazepines, Dexmedetomidine, Remifentanil, Others; Regional Analysis; Market Dynamics: SWOT Analysis, Porter’s Five Forces Analysis; Competitive Landscape; Key Trends and Developments in the Market; 2024-2032
Global Sedation in ICU Setting Market Outlook
The global sedation in ICU setting market size reached a value of around USD 2.99 billion in 2023. The market is expected to grow at a CAGR of 5.60% during the forecast period of 2024-2032 to attain a value of USD 4.14 billion by 2032.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Key Trends in the Market
A state of serenity, relaxation, or sleepiness brought on by medicines is referred to as sedation. During medical or surgical procedures, sedation may be used to help people cope with severely stressful situations or to reduce anxiety. In the ICU setting, sedative drugs are frequently used primarily to alleviate agitation and anxiety, which can be brought on by a variety of different diseases.
- The global market for sedation in ICU settings is rapidly growing due to the increasing geriatric population and their susceptibility to numerous chronic conditions.
- The number of patients being admitted to ICUs and critical care units is rising due to the rising cases of comorbid diseases in the elderly population. This is stimulating the market growth.
- The global sedation in ICU setting market is experiencing growth prospects due to investments in healthcare facility improvement and the adoption of innovations like proper ventilation, larger space for more visiting family members, better drainage systems, and others. Additionally, the increase in peoples' disposable income has pushed them to choose better healthcare options and facilities for their loved ones. This will aid the market expansion in the coming years.
- Sedation is frequently used in the intensive care unit to reduce anxiety and increase comfort in patients who need mechanical ventilation. Critically ill patients typically receive analgesia and sedation to reduce their pain and anxiety, facilitate invasive procedures, reduce their stress levels and oxygen consumption, and improve synchronisation with mechanical breathing. Thus, these advantages contribute to the global market's expansion.
Global Sedation in ICU Setting Market Analysis
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Based on drug class, the market is segmented into propofol, benzodiazepines, dexmedetomidine, and remifentanil, among others. The regional markets for sedation in ICU setting can be divided into North America, Europe, the Asia Pacific, Latin America, the Middle East and Africa. The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis. The report gives a detailed analysis of the following key players in the global sedation in ICU setting market, covering their competitive landscape and latest developments like mergers, acquisitions, investments, and expansion plans.
- Medtronic plc
- AstraZeneca plc
- GlaxoSmithKline plc
- Mylan N.V.
- Teva Pharmaceutical Industries Ltd.
- B. Braun Medical
- Others
Market Share by Drug Class
Based on drug class, the market was dominated by propofol in the historical period. During the forecast period, the segment is expected to dominate the sedation in ICU setting market. This occurs as a result of propofol's rapid uptake as a painkiller and agitation suppressant in mechanical breathing. In the upcoming years, this will help propofol's market expansion, along with the introduction of generic products.
In order to sedate patients in the ICU, propofol is frequently given as a continuous intravenous infusion. Propofol has special qualities that allow it to penetrate the blood-brain barrier quickly, which causes sedation to start working quickly. Additionally, coronavirus (COVID-19) patients in the intensive care unit (ICU) who require mechanical breathing may be sedated with propofol.
Market Share by Region
It is anticipated that North America will dominate the global sedation in ICU setting market. This is because of the increasing older population with comorbid illnesses and increasing number of beds for critical care in developed countries like Canada and the United States. The region's expansion is also being fuelled by the rise in infectious disorders including sepsis and respiratory conditions that require ICU hospitalisation.
Growing hospital ICUs, expanding healthcare infrastructure, and an increase in ICU admissions are some of the key drivers of the global sedation in ICU setting market in developing nations in the Asia Pacific and Latin American regions.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Competitive Landscape
Medtronic plc, founded in 1949 is a leading manufacturer of medical equipment and treatments, including pacemakers, insulin pumps, and treatments for diabetes. It is best recognised for its ground-breaking cardiac devices, including pacemakers that are battery-operated and small. However, it has also put cutting-edge technologies into the market.
AstraZeneca plc, a holding company with its headquarters in the United Kingdom is involved in the creation, production, and research of pharmaceutical goods. To treat diseases in the cancer, cardiovascular, infection, neurological, respiratory, gastrointestinal, and inflammatory domains, the business develops, produces, and sells pharmaceutical and biotechnology products.
GlaxoSmithKline plc, one of the biggest research-based pharmaceutical firms in the world is headquartered in England and produces, promotes, and distributes products for human health. For the purpose of preventing and treating disease, it creates novel vaccinations and specialised medications.
Other market players include Mylan N.V., Teva Pharmaceutical Industries Ltd., and B. Braun Medical, among others.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2018-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Drug Class |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Market Snapshot
6.1 Global
6.2 Region
7 Opportunities and Challenges in the Market
8 Global Sedation in ICU Setting Market Analysis
8.1 Key Industry Highlights
8.2 Global Sedation in ICU Setting Historical Market (2018-2023)
8.3 Global Sedation in ICU Setting Market Forecast (2024-2032)
8.4 Global Sedation in ICU Setting Market by Drug Class
8.4.1 Propofol
8.4.1.1 Market Share
8.4.1.2 Historical Trend (2018-2023)
8.4.1.3 Forecast Trend (2024-2032)
8.4.2 Benzodiazepines
8.4.2.1 Market Share
8.4.2.2 Historical Trend (2018-2023)
8.4.2.3 Forecast Trend (2024-2032)
8.4.3 Dexmedetomidine
8.4.3.1 Market Share
8.4.3.2 Historical Trend (2018-2023)
8.4.3.3 Forecast Trend (2024-2032)
8.4.4 Remifentanil
8.4.4.1 Market Share
8.4.4.2 Historical Trend (2018-2023)
8.4.4.3 Forecast Trend (2024-2032)
8.4.5 Others
8.5 Global Sedation in ICU Setting Market by Region
8.5.1 North America
8.5.1.1 Market Share
8.5.1.2 Historical Trend (2018-2023)
8.5.1.3 Forecast Trend (2024-2032)
8.5.2 Europe
8.5.2.1 Market Share
8.5.2.2 Historical Trend (2018-2023)
8.5.2.3 Forecast Trend (2024-2032)
8.5.3 Asia Pacific
8.5.3.1 Market Share
8.5.3.2 Historical Trend (2018-2023)
8.5.3.3 Forecast Trend (2024-2032)
8.5.4 Latin America
8.5.4.1 Market Share
8.5.4.2 Historical Trend (2018-2023)
8.5.4.3 Forecast Trend (2024-2032)
8.5.5 Middle East and Africa
8.5.5.1 Market Share
8.5.5.2 Historical Trend (2018-2023)
8.5.5.3 Forecast Trend (2024-2032)
9 North America Sedation in ICU Setting Market Analysis
9.1 United States of America
9.1.1 Market Share
9.1.2 Historical Trend (2018-2023)
9.1.3 Forecast Trend (2024-2032)
9.2 Canada
9.2.1 Market Share
9.2.2 Historical Trend (2018-2023)
9.2.3 Forecast Trend (2024-2032)
10 Europe Sedation in ICU Setting Market Analysis
10.1 United Kingdom
10.1.1 Market Share
10.1.2 Historical Trend (2018-2023)
10.1.3 Forecast Trend (2024-2032)
10.2 Germany
10.2.1 Market Share
10.2.2 Historical Trend (2018-2023)
10.2.3 Forecast Trend (2024-2032)
10.3 France
10.3.1 Market Share
10.3.2 Historical Trend (2018-2023)
10.3.3 Forecast Trend (2024-2032)
10.4 Italy
10.4.1 Market Share
10.4.2 Historical Trend (2018-2023)
10.4.3 Forecast Trend (2024-2032)
10.5 Others
11 Asia Pacific Sedation in ICU Setting Market Analysis
11.1 China
11.1.1 Market Share
11.1.2 Historical Trend (2018-2023)
11.1.3 Forecast Trend (2024-2032)
11.2 Japan
11.2.1 Market Share
11.2.2 Historical Trend (2018-2023)
11.2.3 Forecast Trend (2024-2032)
11.3 India
11.3.1 Market Share
11.3.2 Historical Trend (2018-2023)
11.3.3 Forecast Trend (2024-2032)
11.4 ASEAN
11.4.1 Market Share
11.4.2 Historical Trend (2018-2023)
11.4.3 Forecast Trend (2024-2032)
11.5 Australia
11.5.1 Market Share
11.5.2 Historical Trend (2018-2023)
11.5.3 Forecast Trend (2024-2032)
11.6 Others
12 Latin America Sedation in ICU Setting Market Analysis
12.1 Brazil
12.1.1 Market Share
12.1.2 Historical Trend (2018-2023)
12.1.3 Forecast Trend (2024-2032)
12.2 Argentina
12.2.1 Market Share
12.2.2 Historical Trend (2018-2023)
12.2.3 Forecast Trend (2024-2032)
12.3 Mexico
12.3.1 Market Share
12.3.2 Historical Trend (2018-2023)
12.3.3 Forecast Trend (2024-2032)
12.4 Others
13 Middle East and Africa Sedation in ICU Setting Market Analysis
13.1 Saudi Arabia
13.1.1 Market Share
13.1.2 Historical Trend (2018-2023)
13.1.3 Forecast Trend (2024-2032)
13.2 United Arab Emirates
13.2.1 Market Share
13.2.2 Historical Trend (2018-2023)
13.2.3 Forecast Trend (2024-2032)
13.3 Nigeria
13.3.1 Market Share
13.3.2 Historical Trend (2018-2023)
13.3.3 Forecast Trend (2024-2032)
13.4 South Africa
13.4.1 Market Share
13.4.2 Historical Trend (2018-2023)
13.4.3 Forecast Trend (2024-2032)
13.5 Others
14 Market Dynamics
14.1 SWOT Analysis
14.1.1 Strengths
14.1.2 Weaknesses
14.1.3 Opportunities
14.1.4 Threats
14.2 Porter’s Five Forces Analysis
14.2.1 Supplier’s Power
14.2.2 Buyer’s Power
14.2.3 Threat of New Entrants
14.2.4 Degree of Rivalry
14.2.5 Threat of Substitutes
14.3 Key Indicators for Demand
14.4 Key Indicators for Price
15 Competitive Landscape
15.1 Market Structure
15.2 Company Profiles
15.2.1 Medtronic plc
15.2.1.1 Company Overview
15.2.1.2 Product Portfolio
15.2.1.3 Demographic Reach and Achievements
15.2.1.4 Certifications
15.2.2 AstraZeneca plc
15.2.2.1 Company Overview
15.2.2.2 Product Portfolio
15.2.2.3 Demographic Reach and Achievements
15.2.2.4 Certifications
15.2.3 GlaxoSmithKline plc
15.2.3.1 Company Overview
15.2.3.2 Product Portfolio
15.2.3.3 Demographic Reach and Achievements
15.2.3.4 Certifications
15.2.4 Mylan N.V.
15.2.4.1 Company Overview
15.2.4.2 Product Portfolio
15.2.4.3 Demographic Reach and Achievements
15.2.4.4 Certifications
15.2.5 Teva Pharmaceutical Industries Ltd.
15.2.5.1 Company Overview
15.2.5.2 Product Portfolio
15.2.5.3 Demographic Reach and Achievements
15.2.5.4 Certifications
15.2.6 B. Braun Medical
15.2.6.1 Company Overview
15.2.6.2 Product Portfolio
15.2.6.3 Demographic Reach and Achievements
15.2.6.4 Certifications
15.2.7 Others
16 Key Trends and Developments in the Market
List of Key Figures and Tables
1. Global Sedation in ICU Setting Market: Key Industry Highlights, 2018 and 2032
2. Global Sedation in ICU Setting Historical Market: Breakup by Drug Class (USD Billion), 2018-2023
3. Global Sedation in ICU Setting Market Forecast: Breakup by Drug Class (USD Billion), 2024-2032
4. Global Sedation in ICU Setting Historical Market: Breakup by Region (USD Billion), 2018-2023
5. Global Sedation in ICU Setting Market Forecast: Breakup by Region (USD Billion), 2024-2032
6. North America Sedation in ICU Setting Historical Market: Breakup by Country (USD Billion), 2018-2023
7. North America Sedation in ICU Setting Market Forecast: Breakup by Country (USD Billion), 2024-2032
8. Europe Sedation in ICU Setting Historical Market: Breakup by Country (USD Billion), 2018-2023
9. Europe Sedation in ICU Setting Market Forecast: Breakup by Country (USD Billion), 2024-2032
10. Asia Pacific Sedation in ICU Setting Historical Market: Breakup by Country (USD Billion), 2018-2023
11. Asia Pacific Sedation in ICU Setting Market Forecast: Breakup by Country (USD Billion), 2024-2032
12. Latin America Sedation in ICU Setting Historical Market: Breakup by Country (USD Billion), 2018-2023
13. Latin America Sedation in ICU Setting Market Forecast: Breakup by Country (USD Billion), 2024-2032
14. Middle East and Africa Sedation in ICU Setting Historical Market: Breakup by Country (USD Billion), 2018-2023
15. Middle East and Africa Sedation in ICU Setting Market Forecast: Breakup by Country (USD Billion), 2024-2032
16. Global Sedation in ICU Setting Market Structure
Key Questions Answered in the Report
In 2023, the global market for sedation in ICU setting attained a value of nearly USD 2.99 billion.
The market for sedation in ICU setting is projected to grow at a CAGR of 5.60% during the forecast period of 2024-2032.
The sedation in ICU setting market is estimated to witness a healthy growth in the forecast period of 2024-2032 to reach USD 4.14 billion by 2032.
The major drivers of the market include the increasing patient pool, increasing investment towards improvement of healthcare facilities, rise in disposable income of people, rising number of critical care beds in the developed nations, growing number of hospitals ICUs and rising ICU admissions.
A rise in geriatric population and increasing cases of comorbid diseases are the key trends propelling the growth of the market.
The major regions in the sedation in ICU setting market are North America, Europe, the Asia Pacific, Latin America, the Middle East and Africa.
The major players in the market include Medtronic plc, AstraZeneca plc, GlaxoSmithKline plc, Mylan N.V., Teva Pharmaceutical Industries Ltd., and B. Braun Medical, among others.
The benzodiazepines midazolam and lorazepam (and to a lesser extent, diazepam), the short-acting intravenous anaesthetic propofol, and dexmedetomidine are sedatives that are frequently used in the ICU. The sedative properties of the opioid remifentanil led to its usage as a single agent.
Some patients require long-term sedation, perhaps for weeks. The anaesthetic will often be turned off once the issue for which they were admitted to the ICU has been resolved so they can be evaluated. The breathing tube may be removed if they are performing well.
In order to maximise ventilator synchronisation and lessen any discomfort associated with critical illness, patients who were mechanically ventilated in the ICU were traditionally kept thoroughly sedated with ongoing depressive infusions.
Purchase Options
Call us on
Purchase Full Report
Mini Report
$ 2199
$1799
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 3199
$2999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 4199
$3999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 5199
$4999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER